Differential modulation of behavioral effects of cocaine by low- and high-efficacy D1 agonists

Psychopharmacology

Volumn 133, Issue 3, 1997, Pages 283-292

  Spealman, Roger D ^a   Bergman, Jack ^a   Rosenzweig Lipson, Sharon ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b PFIZER INC   (United States)

Author keywords

Cocaine; Cocaine discrimination; D1 agonists; D1 antagonists; D1 partial agonists; Dopamine; Efficacy; SCH 39166; Schedule controlled behavior; SKF 38393; SKF 75670; SKF 81297; SKF 82958; SKF 83189; Squirrel monkeys

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 3 METHYL 1 PHENYL 1H 3 BENZAZEPINE; 3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; ADENYLATE CYCLASE; COCAINE; DOPAMINE RECEPTOR STIMULATING AGENT; ECOPIPAM; SKF 83189; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; IN VITRO STUDY; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MODULATION; NONHUMAN; PRIORITY JOURNAL; SQUIRREL MONKEY; TRAINING;

ANIMALS; COCAINE; CONDITIONING, OPERANT; CYCLIC AMP; DISCRIMINATION (PSYCHOLOGY); DOPAMINE AGONISTS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; MALE; RECEPTORS, DOPAMINE D1; REINFORCEMENT SCHEDULE; SAIMIRI;

EID: 0030763911     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050403     Document Type: Article

References (66)

1. 1 receptor efficacy. Eur J Pharmacol 188:335-347
2. Ariëns EJ (1983) Intrinsic activity: partial agonists and partial antagonists. J Cardiovasc Pharmacol 5: S8-S15
3. 2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in rats. Pharmacol Toxicol 62: 121-130
4. Barrett-Larimore RL, Spealman RD (1996) Reinstatement of cocaine-seeking behavior in a nonhuman primate model of relapse. Soc Neurosci Abstr 22: 925
5. 3 agonists. NIDA Res Monogr (in press)
6. 1 agonists. NIDA Res Monogr 119: 185-189
7. 2 receptor agonists on schedule-controlled behavior of squirrel monkeys. J Pharmacol Exp Ther 273: 40-48
8. 1 receptor ligands: drug interaction studies in squirrel monkeys. J Pharmacol Exp Ther 276: 942-950
9. 5 dopamine receptors in primate brain. J Neurosci 15: 7821-7836
10. 2 receptor function in rats. J Pharmacol Exp Ther 266: 585-592
11. 2 receptors in the brain of several mammalian species. J Neural Transm [Gen Sect] 80: 105-127
12. 1 receptors. J Pharmacol Exp Ther 249: 769-774
13. 1 receptor agonists by squirrel monkeys. Psychopharmacology 125: 97-104
14. 2 receptors in the development of dystonia and hypersensibility in cebus monkeys. Psychopharmacology 103: B8
15. 3H]dopamine in rat brain tissue slices. Biochem Pharmacol 24: 847-852
16. Hurd YL, Kehr J, Ungerstedt U (1988) In vivo microdialysis as a technique to monitor drug transport: correlation of extracellular cocaine levels and dopamine overflow in the rat brain. J Neurochem 51: 1314-1316
17. 1 receptor agonists for stimulating adenylyl cyclase in squirrel monkey and rat. Eur J Pharmacol 246: 39-44
18. Johanson CE, Fischman MW (1989) The pharmacology of cocaine related to its abuse. Pharmacol Rev 41: 3-52
19. 1 dopamine receptor agonist SKF 38393 on behavior maintained by cocaine injection in squirrel monkeys. Psychopharmacology 109: 241-244
20. Kenakin TP (1987) Pharmacological analysis of drug-receptor interaction. Raven Press, New York
21. 1 rat somatomammotrophic cells. J Neurochem 64: 2118-2124
22. Koe BK (1976) Molecular geometry of inhibitors of the uptake of catecholamine and serotonin in synaptosomal preparations of rat brain. J Pharmacol Exp Ther 199: 649-661
23. Kuhar MJ, Pilotte NS (1996) Neurochemical changes in cocaine withdrawal. Trends Pharmacol Sci 17: 260-264
24. Kuhar MJ, Schuster CR (1995) Integrative neurobehavioral pharmacology: focus on cocaine. In: Balster RL, Kuhar M, Schuster CR (eds) Pharmacological aspects of drug dependence: toward an integrated neurobehavioral approach. Springer, New York, pp 53-80
25. 1 dopamine receptor agonists: dopamine receptor selectivity and response to guanine nucleotides in nonhuman primate brain. Soc Neurosci Abstr 19: 1063
26. 2 dopamine receptors in caudate-putamen of nonhuman primates (Macaca fascicularis). J Neurochem 51: 934-943
27. 2+ mobilization in Xenopus oocytes. Proc Natl Acad Sci USA 87: 2196-2200
28. 1 dopamine receptor: its linkage to adenylate cyclase and psychopharmacological effects. Psychopharmacol Bull 22: 593-598
29. 1 receptor antagonist. Eur J Pharmacol 202: 133-134
30. Melia KF, Spealman RD (1991) Pharmacological characterization of the discriminative-stimulus effects of GBR 12909. J Pharmacol Exp Ther 258: 626-632
31. Mello NK, Negus SS (1996) Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14: 375-424
32. Mendelson JH, Mello NK (1996) Management of cocaine abuse and dependence. N Engl J Med 334: 965-972
33. Morse WH, Kelleher RT (1966) Schedules using noxious stimuli. I. Multiple fixed-ratio and fixed-interval termination of schedule complexes. J Exp Anal Behav 9: 267-290
34. 1 receptor antagonists. Eur J Pharmacol 219: 35-44
35. Pettit HO, Justice JB (1989) Dopamine in the nucleus accumbens during cocaine self- administration as studied by in vivo microdialysis. Pharmacol Biochem Behav 34: 899-904
36. Pfeiffer FR, Wilson JW, Weinstock J, Kuo GY, Chambers PAS, Holden KG, Hahn RA, Wardell JR, Alfonso JT, Setler PA, Sarau HM (1982) Dopaminergic activity of substituted 6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-benzazepines. J Med Chem 25: 352-358
37. 1 agonist, SKF 38393, to stimulate adenylyl cyclase activity in primate than in rodent striatum. Eur J Pharmacol 202: 273-276
38. Pulvirenti L, Koob GF (1994) Dopamine receptor agonists, partial agonists and psychostimulant addiction. Trends Pharmacol Sci 15: 374-379
39. Pulvirenti L, Smith D, Koob GF (1994) SDZ 208-911, an aminoergoline with partial dopamine agonist properties, dose dependently increases cocaine self-administration in the rat. Psychopharmacology 113: 518-520
40. 1 agonist SKF 81297. Behav Pharmacol 4: 135-146
41. 1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys. J Pharmacol Exp Ther 267: 765-775
42. 1 receptor agonists in squirrel monkeys. Eur J Pharmacol 260: 237-241
43. 2 agonists in squirrel monkeys. Psychopharmacology 116: 9-18
44. Rosenzweig-Lipson S, Madras BK, Spealman RD, Bergman J (1994b) Comparison of the behavioral effects of SKF 81297, SKF 82958, and cocaine in squirrel monkeys. NIDA Res Monogr 141: 285
45. Rothman RB, Lewis B, Dersch C, Xu H, Radesca L, deCosta BR, Rice KD, Kilburn RB, Akunne HC, Pert A (1993) Identification of a GBR 12935 homolog RL 1111, which is over 4,000-fold selective for the dopamine transporter relative to serotonin and norepinephrine transporters. Synapse 14: 34-39
46. 1 agonists SKF 82958 and SKF 77434 are self-administered by rats. Brain Res 582: 349-352
47. 2-like dopamine receptor agonists. Science 271: 1586-1589
48. Spealman RD (1992) Use of cocaine discrimination techniques for preclinical evaluation of candidate therapeutics for cocaine dependence. NIDA Res Monogr 119: 175-179
49. Spealman RD (1993) How cocaine interacts with brain receptors to affect behavior. In: Hartel CL (ed) Biomedical approaches to illicit drug demand reduction. US Government Printing Office, Washington, DC, pp 63-70
50. 2 partial agonists terguride, SDZ 208-911, and SDZ 208-912. Pharmacol Biochem Behav 51: 661-665
51. Spealman RD, Bergman J, Madras BK, Melia KF (1991) Discriminative stimulus effects of cocaine in squirrel monkeys: involvement of dopamine receptor subtypes. J Pharmacol Exp Ther 258: 945-953
52. 2 dopamine receptors in the behavioral effects of cocaine. Neurochem Int 20: 147S-152S
53. Terry P, Witkin JM, Katz JL (1994) Pharmacological characterization of the novel discriminative stimulus effects of a low dose of cocaine. J Pharmacol Exp Ther 270: 1041-1048
54. 1B receptor subtype. J Biol Chem 269: 27925-27931
55. Tice MAB, Hashemi T, Taylor LA, Duffy RA, McQuade RD (1994) Characterization of the binding of SCH 39166 to the five cloned dopamine receptor subtypes. Pharmacol Biochem Behav 49: 567-571
56. 2 agonists. NIDA Res Monogr 162: 295
57. Tomiyama K, Koshikawa N, Funada K, Oka K, Kobayashi M (1995) In vivo microdialysis evidence for transient dopamine release by benzazepines in rat striatum. J Neurochem 65: 2790-2795
58. 1-like dopamine receptor that couples to activation of phosphoinositide metabolism in brain. J Neurochem 62: 2045-2048
59. 1 receptor agonists display a different intrinsic activity in rat, monkey and human astrocytes. Eur J Pharmacol 269: 121-125
60. 1 dopamine receptor agonists. Synapse 21: 177-187
61. 1 receptor agonists in rhesus monkeys. J Pharmacol Exp Ther 275: 1367-1374
62. 1 receptor agonists in rhesus monkey and rat striata. Abstr CPDD 58th Annual Scientific Meeting, p 146
63. Witkin JM (1994) Pharmacotherapy of cocaine abuse: preclinical development. Neurosci Biobehav Rev 18: 121-142
64. Witkin JM, Nichols DE, Terry P, Katz JL (1991) Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections. J Pharmacol Exp Ther 257: 706-713
65. Woolverton WL, Goldberg LI, Ginos JZ (1984) Intravenous self-administration of dopamine receptor agonists by rhesus monkeys. J Pharmacol Exp Ther 230: 678-683
66. Woolverton WL, Johnson KM (1992) Neurobiology of cocaine abuse. Trends Pharmacol Sci 13: 193-200